Healthcare and Lifesciences
India needs China for critical medicine ingredients, but an ambitious initiative aims to correct that
14 Aug 2022
Despite being the third-largest manufacturer of medicines by volume, India relies on China to supply almost 70 per cent of active pharmaceutical ingredients (APIs) – chemicals that are responsible for the therapeutic effect of those medicines – such as paracetamol for painkillers

Ready to talk?

I want to talk to your experts in:

We work with ambitious leaders and transformative clients who are defining the future. Together, we achieve extraordinary outcomes.

I have read the privacy policy and I agree to its terms.